[1] 陈莹.婴儿痉挛症的治疗和预后研究进展[J].中国循证儿科杂志,2011,6(1):65-70.DOI:10.3969/j.issn.1673-5501. 2011.01.011.
[2] Siebold L, Krueger AC, Abdala JA, et al. Cosyntropin attenuates neuroinflammation in a mouse model of traumatic brain injury[J]. Front Mol Neurosci, 2020, 13:109. DOI: 10.3389/fnmol.2020.00109.
[3] Tibussek D, Klepper J, Korinthenberg R, et al. Treatment of infantile spasms: report of the Interdisciplinary Guideline Committee Coordinated by the German-Speaking Society for Neuropediatrics[J]. Neuropediatrics, 2016, 47(3):139-150. DOI: 10.1055/s-0036-1572411.
[4] Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society[J]. Neurology, 2012, 78(24):1974-1980. DOI: 10.1212/WNL.0b013e318259e2cf.
[5] 陈晓青,董琰.婴儿痉挛症的治疗研究进展[J].实用心脑肺血管病杂志,2020,28(4):10-13.DOI:10.3969/j.issn.1008- 5971.2020.04.003.
[6] 何璐,李金玲,杨旭博,等.A型肉毒毒素注射对痉挛型脑瘫患儿小腿肌肉生长发育影响的前瞻性研究[J].国际医药卫生导报,2022,28(8):1070-1076.DOI:10.3760/cma.j.issn.1007-1245.2022.08.008.
[7] Hahn J, Lee H, Kang HC, et al. Clobazam as an adjunctive treatment for infantile spasms[J]. Epilepsy Behav, 2019, 95:161-165. DOI: 10.1016/j.yebeh.2019.03.040.
[8] Messer R, Knupp KG. Infantile spasms: opportunities to improve care[J]. Semin Neurol, 2020, 40(2):236-245. DOI: 10.1055/s-0040-1705121.
[9] 蔡文仙,孙广斐,郑钦亮,等.促肾上腺皮质激素对婴儿痉挛症患儿淋巴细胞亚群和免疫球蛋白的影响[J].国际医药卫生导报,2021,27(6):837-840.DOI:10.3760/cma.j.issn.1007-1245.2021.06.013.
[10] 夏雪,薛梅,杨春燕,等.超声引导肌肉注射A型肉毒毒素治疗脑卒中后上肢痉挛[J].河北医科大学学报,2021,42(10):1194-1197.DOI:10.3969/j.issn.1007-3205.2021.10.016.
[11] 刘寅淳. 基于光学定位的三维超声引导肌肉注射仪设计研究[D].东华大学,2022.DOI:10.27012/d.cnki.gdhuu.2022. 000571.
[12] 李小寒,尚少梅.基础护理学:实践与学习指导[M].5版.北京:人民卫生出版社,2015:342-344.
[13] 陈殷,阮毅燕,陈瑜毅,等.促肾上腺皮质激素治疗婴儿痉挛症的临床效果[J].广西医学,2019,41(16):2031-2034.DOI:10.11675/j.issn.0253-4304.2019.16.06.
[14] Rishovd A. Pediatric intramuscular injections: guidelines for best practice[J]. MCN Am J Matern Child Nurs, 2014, 39(2):107-112; quiz 113-114. DOI: 10.1097/NMC.0000000000000009.
[15] 郑兰飞,周宝灵,程卫珍,等.硫酸镁湿敷联合艾盐包温灸预防鼠神经生长因子肌肉注射后硬结与疼痛的疗效观察[J].护士进修杂志,2018,33(5):441-443.DOI:10.16821/j.cnki.hsjx.2018.05.017.
[16] 罗蓉,罗淑文.婴儿痉挛症的药物治疗[J].中华实用儿科临床杂志,2023,38(2):108-111.DOI:10.3760/cma.j.cn101070-20220610-00692.
[17] 梁雪芬,李素琳,洪蝶玫.神经内科患者静脉穿刺困难的原因分析及对策[J].中华现代护理杂志,2010,16(24):2961-2962.DOI:10.3760/cma.j.issn.1674-2907.2010. 24.053.
[18] 唐惠林,翟所迪.喜辽妥软膏防治微血管循环障碍效果的系统评价[J].中国循证医学杂志,2010,10(8):946-951.DOI:10.3969/j.issn.1672-2531.2010.08.012.
[19] 卜丽君,陈丽,周昀箐,等.一例促皮质素静脉外渗至局部皮肤坏死的案例解析与改进[J].中国卫生质量管理,2022,29(9):49-51.DOI:10.13912/j.cnki.chqm.2022.29.09.11.
[20] 黄海英.肌肉注射后发生的硬结原因及护理对策[J].中国保健营养(中旬刊),2014,24(1):193-194.
[21] SOREL L, DUSAUCY-BAULOYE A. Findings in 21 cases of Gibbs' hypsarrhythmia; spectacular effectiveness of ACTH[J]. Acta Neurol Psychiatr Belg, 1958, 58(2):130-41.
[22] 中国抗癫痫协会. 临床诊疗指南:癫痫病分册[M].2版.北京.人民卫生出版社,2015:49-51.
[23] Fox JR, Guido-Estrada N, Williams K, et al. Outcomes among patients with infantile spasms treated with hormonal therapy and adjuvant topiramate versus hormonal therapy alone[J]. Epileptic disorders: international epilepsy journal with videotape, 2020, 22(1):33-38. DOI: 10.1684/epd.2020.1133.
[24] Nishimoto S, Shimakawa S, Fukui M, et al. Treatment outcomes for infantile spasms in Japanese children with Down syndrome[J]. Pediatr Int, 2021, 63(12):1495-1503. DOI: 10.1111/ped.14668.
[25] 阮卫云,郅艳华,郭燕燕.婴儿痉挛症的脑电图表现及与ACTH疗效的相关性[J].江西医药,2023,58(4):444-445,448.DOI:10.3969/j.issn.1006-2238.2023.04.017.
[26] Mytinger JR, Weber A, Heyer GL. The response to ACTH is determined early in the treatment of infantile spasms[J]. Epileptic Disord, 2015, 17(1):52-57. DOI: 10.1684/epd.2014.0723.
[27] 万林,杨光,邹丽萍,等.婴儿痉挛症首次促肾上腺皮质激素治疗相关因素与痉挛控制时间的Cox比例风险回归模型分析[J].中国当代儿科杂志,2019,21(9):845-850.DOI:10.7499/j.issn.1008-8830.2019.09.001.
[28] 虎崇康,江逊,张薇.泼尼松龙与促皮质素治疗婴儿痉挛症的疗效 与不良反应及对患儿脑电图的影响[J].河北医学,2019,25(6):911-913.DOI:10.3969/j.issn.1006-6233. 2019.06.008.
[29] Salar S, Moshé SL, Galanopoulou AS. Metabolic etiologies in West syndrome[J]. Epilepsia Open, 2018, 3(2):134-166. DOI: 10.1002/epi4.12102.
|